EGFR/EGFRvIII downstream signaling includes constitutive activation of PIP3K/Akt, RAS/MAPK, and Bcl-Xl and has been implicated in glioblastoma cell proliferation, inhibiting apoptosis and enhancing glioblastoma invasiveness [31]. The gene discussed is BCL2L1; the disease is glioblastoma.